Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene? (Q54532669)

31 May 2018

title

Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene? (English)

1 reference

31 May 2018

author

Kengo Takeuchi

2

1 reference

31 May 2018

author name string

Morio Yamamoto

1

1 reference

31 May 2018

Masaki Shimoji

3

1 reference

31 May 2018

Tomohiro Maniwa

4

1 reference

31 May 2018

Mitsuhiro Isaka

5

1 reference

31 May 2018

Kazuo Nakagawa

6

1 reference

31 May 2018

Yasuhisa Ohde

7

1 reference

31 May 2018

Haruhiko Kondo

8

1 reference

31 May 2018

Takashi Nakajima

9

1 reference

31 May 2018

publication date

1 February 2012

1 reference

31 May 2018

published in

Cancer Science

1 reference

31 May 2018

volume

103

1 reference

31 May 2018

issue

2

1 reference

31 May 2018

page(s)

390-392

1 reference

31 May 2018

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

EML4-ALK fusion is linked to histological characteristics in a subset of lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

EML4-ALK fusion transcripts, but no NPM-, TPM3-, CLTC-, ATIC-, or TFG-ALK fusion transcripts, in non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2011.02136.X

10.1111/J.1349-7006.2011.02136.X

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018